资讯

BioWorld25 天
Sanofi describes new GTPase KRAS mutant inhibitors
Sanofi SA has identified GTPase KRAS (G12D mutant) inhibitors reported to be useful for the treatment of cancer.
The EMBO Journal8 天
Phosphatidylinositol 3‐phosphates—at the interface between cell signalling and membrane ...
Request permissions for this article.